Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prevalence of myocardial infarction polymorphisms in Afyonkarahisar, Western Turkey.

Onrat ST, Akci O, Söylemez Z, Onrat E, Avşar A.

Mol Biol Rep. 2012 Sep;39(9):9257-64. doi: 10.1007/s11033-012-1799-1. Epub 2012 Jul 3.

PMID:
22752805
2.

Prevalence of prothrombotic polymorphisms in Greece.

Gialeraki A, Politou M, Rallidis L, Merkouri E, Markatos C, Kremastinos D, Travlou A.

Genet Test. 2008 Dec;12(4):541-7. doi: 10.1089/gte.2008.0060.

PMID:
19072566
3.

Correlation between common genetic variants and risk factors associated with prediction of cardiovascular diseases in dyslipidemic patients.

Kotaska K, Kolarova J, Kotrcova K, Cepova J, Prusa R.

Genet Test Mol Biomarkers. 2012 Mar;16(3):210-4. doi: 10.1089/gtmb.2011.0129. Epub 2011 Sep 15.

PMID:
21919778
4.

Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.

El-Fattah AAA, Sadik NAH, Sedrak H, Battah A, Nabil M.

Gene. 2018 Jan 30;641:212-219. doi: 10.1016/j.gene.2017.10.043. Epub 2017 Oct 17.

PMID:
29054763
5.

A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.

Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, Yildiz C, Kocak N.

Am J Reprod Immunol. 2010 Feb;63(2):126-36. doi: 10.1111/j.1600-0897.2009.00770.x. Epub 2009 Nov 10.

PMID:
19906129
6.

A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Yilmaz S, Bayan K, Tüzün Y, Batun S, Altintaş A.

J Thromb Thrombolysis. 2006 Dec;22(3):205-12.

PMID:
17111197
7.

Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations.

Ozdemir O, Yenicesu GI, Silan F, Köksal B, Atik S, Ozen F, Göl M, Cetin A.

Genet Test Mol Biomarkers. 2012 Apr;16(4):279-86. doi: 10.1089/gtmb.2011.0191. Epub 2011 Nov 2.

PMID:
22047507
8.

Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.

Oztuzcu S, Ergun S, Ulaşlı M, Nacarkahya G, Iğci YZ, Iğci M, Bayraktar R, Tamer A, Çakmak EA, Arslan A.

Mol Biol Rep. 2014 Jun;41(6):3671-6. doi: 10.1007/s11033-014-3231-5. Epub 2014 Feb 15.

PMID:
24532105
9.

Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.

French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, Liu-Stratton Y, Pohorence J, Szymanski D, Goldschmidt-Clermont P, White HD, Browett PJ, Cooke G.

Am Heart J. 2003 Jan;145(1):118-24.

PMID:
12514663
10.
11.

Genetic polymorphisms and coronary artery disease in the south of France.

Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I.

Thromb Haemost. 2000 Feb;83(2):212-6.

PMID:
10739375
12.

Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males.

Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, Dardik R, Baron Z, Seligsohn U.

Blood. 1999 Apr 1;93(7):2186-90.

13.

Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis.

Zee RY, Cook NR, Cheng S, Erlich HA, Lindpaintner K, Ridker PM.

J Thromb Haemost. 2006 Feb;4(2):341-8.

14.

Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.

Yioti GG, Panagiotou OA, Vartholomatos GA, Kolaitis NI, Pappa CN, Evangelou E, Stefaniotou MI.

Ophthalmic Genet. 2013 Sep;34(3):130-9. doi: 10.3109/13816810.2012.746376. Epub 2013 Jan 4.

PMID:
23289804
15.

Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension.

Bayan K, Tüzün Y, Yilmaz S, Canoruc N, Dursun M.

J Thromb Thrombolysis. 2009 Jul;28(1):57-62. doi: 10.1007/s11239-008-0244-8. Epub 2008 Aug 7.

PMID:
18685811
16.

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.

Thromb Res. 2012 Sep;130(3):e43-51. doi: 10.1016/j.thromres.2012.06.015. Epub 2012 Jul 6.

PMID:
22771216
17.

Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots.

Conkbayir C, Fahrioglu Yamaci R, Gencer P, Barin B, Yucel G, Yildiz CE, Ugurlucan M, Basak AN.

Heart Surg Forum. 2017 Oct 30;20(5):E223-E229. doi: 10.1532/hsf.1587.

PMID:
29087287
18.

Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.

Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran RS.

Am J Reprod Immunol. 2008 Nov;60(5):426-31. doi: 10.1111/j.1600-0897.2008.00640.x.

PMID:
18803625
19.

Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.

Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.

Genet Test Mol Biomarkers. 2010 Feb;14(1):23-7. doi: 10.1089/gtmb.2009.0039.

PMID:
19929406
20.

Genetic risk factors in myocardial infarction at young age.

Incalcaterra E, Hoffmann E, Averna MR, Caimi G.

Minerva Cardioangiol. 2004 Aug;52(4):287-312. Review.

PMID:
15284679

Supplemental Content

Support Center